Feline urine marking: fluoxetine vs placebo — POSSIBLE

In cats with urine marking, does fluoxetine vs placebo reduce marking episodes?

Shelf #306 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: Fluoxetine reduced feline urine spraying versus placebo in a randomized placebo-controlled double-blind clinical trial (Pryor 2001): the mean weekly rate of spraying episodes in treated cats was 8.6 (± 2.0) at baseline, fell significantly by week 2 (1.7 ± 0.6), and fell further by weeks 7 and 8 (0.4 ± 0.2), while the mean weekly spraying rate of cats receiving placebo was 7.8 (± 1.5) at baseline, decreased only slightly during week 1 (5.5 ± 1.8), and did not decline further. A second, double-masked trial found fluoxetine equivalent to clomipramine over 16 weeks, with efficacy increasing on treatment beyond 8 weeks and most cats returning to marking after abrupt drug withdrawal (Hart 2005). POSSIBLE rather than higher because both trials are very small (17 and 22 cats) and spraying was recorded by owners. Note on sources: the anchor named for this topic in the draft list (Hart 2005) has no placebo arm — it is a fluoxetine-vs-clomipramine trial — so the versus-placebo evidence on this shelf is Pryor 2001, carded first. Drafted Nov 10, 2026 (VetMed build, topic #306); all figures from abstracts fetched and verified at drafting.

Pryor 2001: spraying fell from 8.6 to 0.4 episodes/week on fluoxetine vs no further decline on placebo (17 cats)

Randomized placebo-controlled double-blind clinical trial (record's own design wording)

Who: Cats: 17 neutered cats > 1 year old with objectionable urine spraying behaviour (the record's MeSH indexes Male only). Owners recorded urine-spraying events for 2 weeks at baseline; cats that vertically marked a mean of ≥ 3 times per week were treated for 8 weeks with fluoxetine or fish-flavored liquid placebo — 9 cats received fluoxetine, per the adverse-reaction denominator in the record. If urine spraying was not reduced by 70% by weeks 4 through 5, the dosage was increased by 50% for weeks 7 and 8; after discontinuation at 8 weeks, owners recorded daily urine marks for another 4 weeks. Outcomes are therefore owner-recorded event counts in a trial stated as double-blind in the record.

Result: The mean (± SE) weekly rate of spraying episodes in treated cats was 8.6 (± 2.0) at baseline, decreased significantly by week 2 (1.7 ± 0.6), and continued to decrease by weeks 7 and 8 (0.4 ± 0.2). The mean weekly spraying rate of cats receiving placebo was 7.8 (± 1.5) at baseline, decreased only slightly during week 1 (5.5 ± 1.8), and did not decline further. When treatment was discontinued after 8 weeks, the spraying rate of cats that had received treatment varied; the record also states that the frequency of spraying before treatment is predictive of the spraying rate when the drug is discontinued. The main adverse reaction to the drug was a reduction in food intake, observed in 4 of 9 treated cats. The record does not state the fluoxetine dose in mg/kg, and none is carded here.

Watch out: Only 17 cats, owner-recorded outcomes, and a dose-escalation step partway through (a 50% increase for inadequate responders) mean the carded rates describe the trialled regimen as a whole, not a fixed dose. The fall in the placebo group in week 1 (7.8 to 5.5 episodes/week) is a reminder that some improvement happens without drug — the separation is in the further fall to 0.4/week on fluoxetine versus no further decline on placebo.

Pryor PA, Hart BL, Cliff KD, Bain MJ. Effects of a selective serotonin reuptake inhibitor on urine spraying behavior in cats. J Am Vet Med Assoc. 2001;219(11):1557-1561. PMID: 11759993. Registry ID: none in the record. MeSH: Animals · Behavior, Animal · Cat Diseases · Cats · Eating · Fluoxetine · Male · Selective Serotonin Reuptake Inhibitors · Time Factors · Treatment Outcome · Urination Disorders

Hart 2005: fluoxetine and clomipramine equivalent over 16 weeks; marking returned in most cats after abrupt withdrawal (22 cats)

Positive-controlled, double-masked clinical trial (record's own design wording)

Who: Cats: 22 neutered cats (2 females, 20 males) ≥ 1 year old with objectionable urine marking that marked vertically ≥ 3 times/week, treated with fluoxetine (1 mg/kg [0.45 mg/lb], q 24 h, PO) or clomipramine (0.5 mg/kg [0.23 mg/lb], q 24 h, PO) for 16 weeks in a positive-controlled, double-masked clinical trial (the record's publication types include Randomized Controlled Trial). Recurrence of marking was determined after abrupt withdrawal of fluoxetine at 16 or 32 weeks, and cats that returned to marking were retreated and compared with their initial treatment.

Result: Efficacy of fluoxetine and clomipramine was similar. Treatment > 8 weeks revealed increasing efficacy in reduction of marking. Return of marking after termination of fluoxetine administration occurred in most cats. Cats successfully treated initially with fluoxetine responded similarly to repeated treatment — in the record's conclusion, a second course of treatment can be expected to be as effective as the first. The abstract reports no numeric marking rates for either drug, and none are carded here.

Watch out: This trial has no placebo arm — it cannot by itself answer this shelf's versus-placebo question, which is why Pryor 2001 is carded first; what Hart 2005 adds is the comparison against the established alternative (clomipramine, equivalent), the time course (better after 8 weeks, so an 8-week trial of treatment may stop too early), and the withdrawal finding (most cats resume marking after abrupt withdrawal). Masking is stated as 'double-masked'; the word randomized appears in the publication types, not in the abstract's design line.

Hart BL, Cliff KD, Tynes VV, Bergman L. Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats. J Am Vet Med Assoc. 2005;226(3):378-382. PMID: 15702686. Registry ID: none in the record. MeSH: Administration, Oral · Animals · Behavior, Animal · Cat Diseases · Cats · Clomipramine · Drug Administration Schedule · Female · Fluoxetine · Male · Recurrence · Selective Serotonin Reuptake Inhibitors · Treatment Outcome · Urination Disorders

Synthesis: fluoxetine cuts spraying versus placebo in one small blinded trial, matches clomipramine in another — and usually needs to be continued

Synthesis

Who: Synthesis of the cards above: Pryor 2001 (randomized placebo-controlled double-blind trial, 17 neutered cats) and Hart 2005 (positive-controlled double-masked trial, 22 neutered cats, fluoxetine vs clomipramine).

Result: Against placebo, fluoxetine took mean weekly spraying from 8.6 episodes to 0.4 by weeks 7-8 while placebo cats did not decline further after week 1 (Pryor 2001); against clomipramine it was equivalent, with benefit still increasing beyond 8 weeks and a second course working as well as the first after relapse (Hart 2005). Two small blinded trials pointing the same way carry POSSIBLE; the tiny samples and owner-recorded counts are what hold it there. Reduced food intake (4 of 9 treated cats in Pryor 2001) is the adverse effect on the face of the records.

Watch out: Both records are in cats marking at least 3 times a week with vertical spraying — the evidence does not address periuria (toileting outside the box on horizontal surfaces), a different problem with different causes, and most successfully treated cats resumed marking when fluoxetine was stopped abruptly.

Synthesis of Pryor PA et al. PMID: 11759993; Hart BL et al. PMID: 15702686. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.